Heterologous protein incites abnormal plasma cell accumulation and autoimmunity in MRL-MpJ mice

References

• Harley JB, Alarcon-Riquelme ME, Criswell LA, Jacob CO, Kimberly RP, Moser KL, Tsao BP, Vyse TJ, Langefeld CD, Nath SK, . Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet. 2008; 40:204–210.
   PubMed Web of Science ®Google Scholar
• Kozyrev SV, Abelson AK, Wojcik J, Zaghlool A, Linga Reddy MV, Sanchez E, Gunnarsson I, Svenungsson E, Sturfelt G, Jonsen A, . Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus. Nat Genet. 2008; 40:211–216.
   PubMed Web of Science ®Google Scholar
• Graham RR, Cotsapas C, Davies L, Hackett R, Lessard CJ, Leon JM, Burtt NP, Guiducci C, Parkin M, Gates C, . Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus. Nat Genet. 2008; 40:1059–1061.
   PubMed Web of Science ®Google Scholar
• Vas J, Monestier M. Immunology of mercury. Ann NY Acad Sci. 2008; 1143:240–267.
   PubMed Web of Science ®Google Scholar
• Satoh M, Kuroda Y, Yoshida H, Behney KM, Mizutani A, Akaogi J, Nacionales DC, Lorenson TD, Rosenbauer RJ, Reeves WH. Induction of lupus autoantibodies by adjuvants. J Autoimmun. 2003; 21:1–9.
   PubMed Web of Science ®Google Scholar
• Lee PY, Kumagai Y, Li Y, Takeuchi O, Yoshida H, Weinstein J, Kellner ES, Nacionales D, Barker T, Kelly-Scumpia K, . TLR7-dependent and FcgammaR-independent production of type I interferon in experimental mouse lupus. J Exp Med. 2008; 205:2995–3006.
   PubMed Web of Science ®Google Scholar
• Watson ML, Rao JK, Gilkeson GS, Ruiz P, Eicher EM, Pisetsky DS, Matsuzawa A, Rochelle JM, Seldin MF. Genetic analysis of MRL-lpr mice: relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci. J Exp Med. 1992; 176:1645–1656.
   PubMed Web of Science ®Google Scholar
• Gu L, Weinreb A, Wang XP, Zack DJ, Qiao JH, Weisbart R, Lusis AJ. Genetic determinants of autoimmune disease and coronary vasculitis in the MRL-lpr/lpr mouse model of systemic lupus erythematosus. J Immunol. 1998; 161:6999–7006.
   PubMed Web of Science ®Google Scholar
• Vidal S, Kono DH, Theofilopoulos AN. Loci predisposing to autoimmunity in MRL-Fas lpr and C57BL/6-Faslpr mice. J Clin Invest. 1998; 101:696–702.
   PubMed Web of Science ®Google Scholar
• Pisetsky DS, Caster SA, Roths JB, Murphy ED. Ipr gene control of the anti-DNA antibody response. J Immunol. 1982; 128:2322–2325.
   PubMed Web of Science ®Google Scholar
• Izui S, Kelley VE, Masuda K, Yoshida H, Roths JB, Murphy ED. Induction of various autoantibodies by mutant gene lpr in several strains of mice. J Immunol. 1984; 133:227–233.
   PubMed Web of Science ®Google Scholar
• Bolland S, Yim YS, Tus K, Wakeland EK, Ravetch JV. Genetic modifiers of systemic lupus erythematosus in FcgammaRIIB( − / − ) mice. J Exp Med. 2002; 195:1167–1174.
   PubMed Web of Science ®Google Scholar
• McGaha TL, Karlsson MC, Ravetch JV. FcgammaRIIB deficiency leads to autoimmunity and a defective response to apoptosis in Mrl-MpJ mice. J Immunol. 2008; 180:5670–5679.
   PubMedGoogle Scholar
• Nijnik A, Ferry H, Lewis G, Rapsomaniki E, Leung JC, Daser A, Lambe T, Goodnow CC, Cornall RJ. Spontaneous B cell hyperactivity in autoimmune-prone MRL mice. Int Immunol. 2006; 18:1127–1137.
   Google Scholar
• Rudolph EH, Congdon KL, Sackey FN, Fitzsimons MM, Foster MH. Humoral autoimmunity to basement membrane antigens is regulated in C57BL/6 and MRL/MpJ mice transgenic for anti-laminin Ig receptors. J Immunol. 2002; 168:5943–5953.
   Google Scholar
• Groom JR, Fletcher CA, Walters SN, Grey ST, Watt SV, Sweet MJ, Smyth MJ, Mackay CR, Mackay F. BAFF and MyD88 signals promote a lupuslike disease independent of T cells. J Exp Med. 2007; 204:1959–1971.
   PubMed Web of Science ®Google Scholar
• Tsao PY, Jiao J, Ji MQ, Cohen PL, Eisenberg RA. T cell-independent spontaneous loss of tolerance by anti-double-stranded DNA B cells in C57BL/6 mice. J Immunol. 2008; 181:7770–7777.
   PubMed Web of Science ®Google Scholar
• Bolland S, Ravetch JV. Spontaneous autoimmune disease in Fc(gamma)RIIB-deficient mice results from strain-specific epistasis. Immunity. 2000; 13:277–285.
   PubMed Web of Science ®Google Scholar
• Hebert MJ, Takano T, Papayianni A, Rennke HG, Minto A, Salant DJ, Carroll MC, Brady HR. Acute nephrotoxic serum nephritis in complement knockout mice: relative roles of the classical and alternate pathways in neutrophil recruitment and proteinuria. Nephrol Dial Transplant. 1998; 13:2799–2803.
   PubMed Web of Science ®Google Scholar
• Quigg RJ, He C, Lim A, Berthiaume D, Alexander JJ, Kraus D, Holers VM. Transgenic mice overexpressing the complement inhibitor crry as a soluble protein are protected from antibody-induced glomerular injury. J Exp Med. 1998; 188:1321–1331.
   PubMedGoogle Scholar
• Quigg RJ, Kozono Y, Berthiaume D, Lim A, Salant DJ, Weinfeld A, Griffin P, Kremmer E, Holers VM. Blockade of antibody-induced glomerulonephritis with Crry-Ig, a soluble murine complement inhibitor. J Immunol. 1998; 160:4553–4560.
   PubMedGoogle Scholar
• McGaha TL, Sorrentino B, Ravetch JV. Restoration of tolerance in lupus by targeted inhibitory receptor expression. Science. 2005; 307:590–593.
   PubMed Web of Science ®Google Scholar
• Meyers KE, Allen J, Gehret J, Jacobovits A, Gallo M, Neilson EG, Hopfer H, Kalluri R, Madaio MP. Human antiglomerular basement membrane autoantibody disease in XenoMouse II. Kidney Int. 2002; 61:166–173.
   Google Scholar
• Lu TT, Cyster JG. Integrin-mediated long-term B cell retention in the splenic marginal zone. Science. 2002; 297:409–412.
   PubMed Web of Science ®Google Scholar
• Furukawa F, Tanaka H, Sekita K, Nakamura T, Horiguchi Y, Hamashima Y. Dermatopathological studies on skin lesions of MRL mice. Arch Dermatol Res. 1984; 276:186–194.
   PubMed Web of Science ®Google Scholar
• Eisenberg R. Why can't we find a new treatment for SLE?. J Autoimmun. 2009; 32:223–230.
   PubMed Web of Science ®Google Scholar
• Mohan C, Morel L, Yang P, Watanabe H, Croker B, Gilkeson G, Wakeland EK. Genetic dissection of lupus pathogenesis: a recipe for nephrophilic autoantibodies. J Clin Invest. 1999; 103:1685–1695.
   PubMed Web of Science ®Google Scholar
• Morel L, Croker BP, Blenman KR, Mohan C, Huang G, Gilkeson G, Wakeland EK. Genetic reconstitution of systemic lupus erythematosus immunopathology with polycongenic murine strains. Proc Natl Acad Sci USA. 2000; 97:6670–6675.
   PubMed Web of Science ®Google Scholar
• Unni KK, Holley KE, McDuffie FC, Titus JL. Comparative study of NZB mice under germfree and conventional conditions. J Rheumatol. 1975; 2:36–44.
   PubMedGoogle Scholar
• Maldonado MA, Kakkanaiah V, MacDonald GC, Chen F, Reap EA, Balish E, Farkas WR, Jennette JC, Madaio MP, Kotzin BL, . The role of environmental antigens in the spontaneous development of autoimmunity in MRL-lpr mice. J Immunol. 1999; 162:6322–6330.
   PubMed Web of Science ®Google Scholar
• Klonowski KD, Monestier M. Heavy chain revision in MRL mice: a potential mechanism for the development of autoreactive B cell precursors. J Immunol. 2000; 165:4487–4493.
   Google Scholar
• Zemlin M, Ippolito GC, Zemlin C, Link J, Monestier M, Schroeder HWJr. Adult lupus-prone MRL/MpJ2+ mice express a primary antibody repertoire that differs in CDR-H3 length distribution and hydrophobicity from that expressed in the C3H parental strain. Mol Immunol. 2005; 42:789–798.
   Google Scholar
• Radic MZ, Mackle J, Erikson J, Mol C, Anderson WF, Weigert M. Residues that mediate DNA binding of autoimmune antibodies. J Immunol. 1993; 150:4966–4977.
   PubMed Web of Science ®Google Scholar
• Krishnan MR, Jou NT, Marion TN. Correlation between the amino acid position of arginine in VH-CDR3 and specificity for native DNA among autoimmune antibodies. J Immunol. 1996; 157:2430–2439.
   PubMed Web of Science ®Google Scholar
• Seal SN, Hoet RM, Raats JM, Radic MZ. Analysis of autoimmune bone marrow by antibody-phage display: somatic mutations and third complementarity-determining region arginines in anti-DNA gamma and kappa V genes. Arthritis Rheum. 2000; 43:2132–2138.
   Google Scholar
• Seal SN, Monestier M, Radic MZ. Diverse roles for the third complementarity determining region of the heavy chain (H3) in the binding of immunoglobulin Fv fragments to DNA, nucleosomes and cardiolipin. Eur J Immunol. 2000; 30:3432–3440.
   PubMed Web of Science ®Google Scholar
• Klonowski KD, Primiano LL, Monestier M. Atypical VH-D-JH rearrangements in newborn autoimmune MRL mice. J Immunol. 1999; s162:1566–1572.
   Google Scholar
• Chen C, Nagy Z, Prak EL, Weigert M. Immunoglobulin heavy chain gene replacement: a mechanism of receptor editing. Immunity. 1995; 3:747–755.
   PubMedGoogle Scholar
• Brard F, Shannon M, Prak EL, Litwin S, Weigert M. Somatic mutation and light chain rearrangement generate autoimmunity in anti-single-stranded DNA transgenic MRL/lpr mice. J Exp Med. 1999; 190:691–704.
   PubMedGoogle Scholar
• Rubio CF, Kench J, Russell DM, Yawger R, Nemazee D. Analysis of central B cell tolerance in autoimmune-prone MRL/lpr mice bearing autoantibody transgenes. J Immunol. 1996; 157:65–71.
   PubMedGoogle Scholar
• Fatenejad S, Peng SL, Disorbo O, Craft J. Central T cell tolerance in lupus-prone mice: influence of autoimmune background and the lpr mutation. J Immunol. 1998; 161:6427–6432.
   Google Scholar
• Santiago-Raber ML, Amano H, Amano E, Fossati-Jimack L, Swee LK, Rolink A, Izui S. Evidence that Yaa-induced loss of marginal zone B cells is a result of dendritic cell-mediated enhanced activation. J Autoimmun. 2010; 34:349–355.
   Google Scholar
• Xu H, Li H, Suri-Payer E, Hardy RR, Weigert M. Regulation of anti-DNA B cells in recombination-activating gene-deficient mice. J Exp Med. 1998; 188:1247–1254.
   PubMed Web of Science ®Google Scholar
• Martin F, Kearney JF. Positive selection from newly formed to marginal zone B cells depends on the rate of clonal production, CD19, and btk. Immunity. 2000; 12:39–49.
   PubMed Web of Science ®Google Scholar
• Qian Y, Conway KL, Lu X, Seitz HM, Matsushima GK, Clarke SH. Autoreactive MZ and B-1 B-cell activation by Faslpr is coincident with an increased frequency of apoptotic lymphocytes and a defect in macrophage clearance. Blood. 2006; 108:974–982.
   PubMed Web of Science ®Google Scholar
• Nimmerjahn F, Ravetch JV. Fc-receptors as regulators of immunity. Adv Immunol. 2007; 96:179–204.
   PubMed Web of Science ®Google Scholar
• Loh C, Pau E, Lajoie G, Li TT, Baglaenko Y, Cheung YH, Chang NH, Wither JE. Epistatic suppression of fatal autoimmunity in New Zealand black bicongenic mice. J Immunol. 2011; 186:5845–5853.
   Google Scholar
• Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA, Harley JB. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med. 2003; 349:1526–1533.
   PubMed Web of Science ®Google Scholar